1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. BEAM THERAPEUTICS INC
Beam Therapeutics Inc
XNAS: BEAM
29.53 -2.32 (-7.28%)
2.3M
XNAS Volume

XNAS 14 May, 2026 4:16 PM (EDT)

Watchlist

Portfolio

Alert

Beam Therapeutics Inc - BEAM - stock price prediction, stock price target, analyst ratings from 17 analysts

Beam Therapeutics Inc has a share price target of US$ 51, revenue growth forecast of -47.6%, and profit growth estimate of -481.0% for FY26, based on top 17 analyst calls.